Document Detail


Prevalence of severity of hypoxemia following clinical voluntary hyperventilation.
MedLine Citation:
PMID:  8815969     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The voluntary hyperventilation (VHV) test is used in many clinical examinations. However, arterial hypoxemia following a clinical VHV test is not a well-studied phenomenon. We analyzed the arterial blood gases (ABGs) of 61 patients during a VHV test. The ABG were taken prior to (PaO2-Prior), immediately following (PaO2-Immediate), and 5 min after (PaO2-After) the VHV test. The patients' average PaO2 rose significantly (p < 0.0001) from the PaO2-Prior (88 +/- 8 mm Hg; mean +/- SD) to the PaO2-Immediate (118 +/- 13 mm Hg) and then dropped significantly (p < 0.0001) to the PaO2-After (74 +/- 16 mm Hg). Two of the 20 patients who experienced an angina pectoris attack (AP(+)) following the VHV test showed severe arterial hypoxemia (PaO2-After < 60 mm Hg), whereas 9 of the 41 patients who did not experience an angina pectoris attack (AP(-)) showed a PaO2-After < 60 mm Hg. The PaO2-After did not correlate with the PaO2-Prior. The decrease in the PaO2-Prior to After did not correlate significantly with the left ventricular ejection fraction rate (n = 58, r = 0.18, not significant). However, the decrease in the PaO2-Prior to After correlated well with the degree of recovery of the PaCO2 following the VHV test (r = -0.69, p < 0.0001). The age, gender ratio, changes in arterial blood gases, number of patients who experienced PaO2-After < 60 mm Hg, and left-ventricular ejection fraction rate were not significantly different between the AP(-) and AP(+) groups. Posthyperventilation hypoxemia developed frequently following the VHV test during coronary angiography. Although this arterial hypoxemia was not directly correlated with the occurrence of AP attacks following VHV in this study, continuous SaO2 monitoring is recommended whenever a VHV test is used as a diagnostic technique to avoid the potentially deleterious effects of arterial hypoxemia.
Authors:
K Chin; M Ohi; M Fujita; T Ishimura; A Wakabayashi; K Kuno
Related Documents :
8522709 - Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angi...
3063419 - Reversible arterial spasm in an adolescent with primary oxalosis.
18599269 - Optimal 3d reconstruction of coronary arteries for 3d clinical assessment.
7015819 - Complete denervation of the heart (autotransplantation) for treatment of severe, refrac...
10628959 - Model-based morphological segmentation and labeling of coronary angiograms.
2531509 - Coronary artery spasm complicating ptca: role of intracoronary nitroglycerin.
24725909 - Outcomes of covered versus bare-metal balloon-expandable stents for aortoiliac occlusiv...
15108049 - Acute subdural haematoma due to ruptured intracranial aneurysms.
8535859 - Regional differences in cerebral vasomotor control by nitric oxide.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Respiration; international review of thoracic diseases     Volume:  63     ISSN:  0025-7931     ISO Abbreviation:  Respiration     Publication Date:  1996  
Date Detail:
Created Date:  1996-12-16     Completed Date:  1996-12-16     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0137356     Medline TA:  Respiration     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  223-9     Citation Subset:  IM    
Affiliation:
Department of Clinical Physiology, Kyoto University, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anoxia / physiopathology*
Arteries
Female
Gases / blood
Heart / physiopathology
Humans
Hyperventilation / blood*
Male
Middle Aged
Oxygen / blood
Partial Pressure
Volition
Chemical
Reg. No./Substance:
0/Gases; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A comparison of pathophysiological changes during hypobaric and normobaric hypoxia in rats.
Next Document:  Evaluation of the use of three different devices for nocturnal oxygen therapy in COPD patients.